If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.60
Bid: 150.20
Ask: 153.00
Change: -1.40 (-0.92%)
Spread: 2.80 (1.864%)
Open: 154.20
High: 154.20
Low: 150.20
Prev. Close: 153.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding COVID-19

26 Mar 2020 13:12

RNS Number : 7417H
Apax Global Alpha Limited
26 March 2020
 

 

(LSE: APAX)

 

Apax Global Alpha Limited

 

Statement regarding COVID-19

 

The Board and the Investment Manager of Apax Global Alpha are monitoring the evolving COVID-19 crisis closely and would like to provide an update to shareholders as to relevant developments and what may be the potential impacts for Apax Global Alpha ("AGA").

 

Background

 

The COVID-19 crisis is unprecedented and has substantial humanitarian, social, and economic consequences. At this stage, it is still rapidly and dynamically evolving with uncertainty impacting global markets. Whilst governments and central banks have started to take wide-reaching actions to counter the near-term effects of the crisis, there remains a significant level of uncertainty as to how the crisis will continue to evolve. This heightened level of uncertainty, together with the short-term impact of extreme measures taken by governments across the world aimed at slowing down the spread of the coronavirus, has led to a high level of volatility in public equity and corporate credit markets. In the period from 19 February 2020 to 25 March 2020, the S&P 5001 price index has declined by 26.9% and average loan pricing in the S&P/LSTA US Leveraged Loan Index2 has dropped from 96.7 to 77.9 over the same period.

 

Update from the Investment Manager

 

Against this backdrop, the Investment Manager has been actively engaging with its Investment Adviser, Apax Partners, and can provide the following update:

 

The extent and nature of the economic impact of COVID-19 is unprecedented and unlike a typical cyclical downturn. The population lockdowns and pausing of many types of economic activity is causing unusual effects in the economy in general, and AGA's Private Equity portfolio is not exempt.

 

The Investment Adviser's current priority is on the Apax Funds' private equity portfolio. Portfolio companies are enacting their own measures to ensure the safety of employees and continuation of business operations. In addition to this, the Investment Adviser's deal teams are engaging proactively with management along with the advice and assistance of the Operational Excellence Practice to monitor developments and to come up with immediate actions and contingency plans.

 

The Investment Adviser is carefully monitoring liquidity in each portfolio company. In this context, it is worthwhile to note that average debt levels in AGA's Private Equity portfolio were relatively low heading into the crisis (Net Debt/EBITDA multiple: 3.7x at 31 December 2019).

 

We believe that much of Apax Funds' private equity portfolio is in sectors that are less severely impacted by the crisis. The private equity portfolio has limited exposure to energy and little exposure to travel. Least impacted portfolio companies include those that operate in the Tech & Telco sector or are services businesses that are not in-person. A subset of the portfolio is, however, currently seeing more severe impacts. This includes but is not limited to in-person retail and education-focused businesses. Whilst the Investment Adviser has not seen large reductions of run-rate revenue in most of the Apax Funds' private equity portfolio, if shutdowns were to persist for extended periods of time, we would expect more of the portfolio to be impacted more meaningfully.

 

Given significant volatility in capital markets, it is also likely there will be a decline in AGA's Net Asset Value in the short term. Where public market multiples are used to value portfolio companies, we expect lower multiples to have an impact on the valuation of portfolio companies at 31 March 2020 compared to the prior quarter. Private equity is an asset class where value is generated in the long term. In addition, history has shown the most attractive investment vintages have directly followed periods of economic dislocation. Given Apax Partners' strong long-term track record, there will likely be attractive private equity investment opportunities in the period ahead.

 

We are also closely monitoring the Derived Investments portfolio and AGA's liquidity position. As outlined in the Annual Results at 31 December 2019, there has been an increasing focus on Derived Debt and reduced exposure to Derived Equity. In addition, a larger proportion of Derived Debt investments (39% of Derived Debt at 31 December 2019) have been in first lien instruments which has improved risk exposures.

 

As at 25 March 2020, AGA's available liquidity is EUR 179.1m, consisting of EUR 39.1m cash and cash equivalents, and a committed facility of EUR 140.0m which remains undrawn.

 

In terms of their own operations, the Investment Manager and Investment Adviser remain fully operational with business continuity practices working as anticipated.

 

Tim Breedon CBE, Chairman of Apax Global Alpha, said:

 

"The Board is confident that Apax Partners' nearly five decades of investment experience across many economic cycles will be highly beneficial to AGA in this current crisis. The Board also remains positive in AGA's ability to withstand the current market developments and we will continue to monitor developments closely and will provide a detailed update to investors on 15 May 2020 in our Q1 reporting."

 

 

Contact details

 

Investor enquiries

Media enquiries

Sarah Page

IR Manager - AGA

Andrew Kenny

Head of Communications

Telephone: +44 (0)20 7666 6573

Telephone: +44 (0) 20 7872 6371

Email: sarah.page@apax.com

Email: andrew.kenny@apax.com

 

Notes

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

2.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

Footnotes

 

1. Bloomberg as at 25 March 2020

2. Bloomberg as at 19 February 2020 and 25 March 2020 respectively

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in debt and equities derived from the insights gained via Apax Partners' Private Equity activities. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

 

About Apax Partners LLP

 

Apax Partners is a leading global private equity advisory firm and over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of c.€40 billion. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com. Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEADDKAFFEEFA
Date   Source Headline
14th Mar 20197:00 amRNSNotice of AGM
13th Mar 20196:05 pmRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSUpdated Key Information Document
5th Mar 20197:00 amRNS2018 Annual Dividend
5th Mar 20197:00 amRNS2018 Annual Report and Accounts
5th Mar 20197:00 amRNS2018 Final Results
26th Feb 201911:42 amRNSExits from Exact Software and AssuredPartners
29th Jan 20197:00 amRNSApax Funds' Valuations as at 31 December 2018
21st Dec 20181:48 pmRNSDirector/PDMR Shareholding
21st Dec 201812:09 pmRNSInclusion in FTSE 250 Index
19th Dec 20186:30 pmRNSShire
27th Nov 201810:00 amRNSPDMR Dealing - Share Transfers
23rd Nov 20183:07 pmRNSDirector Dealings - Chris Ambler
14th Nov 20187:00 amRNSNotice of Annual Results
7th Nov 20187:00 amRNSNew revolving credit facility
7th Nov 20187:00 amRNSQuarterly results for the period ended 30 Sep 2018
13th Sep 20184:29 pmRNSDirector Dealings - Chris Ambler
5th Sep 20185:12 pmRNSNotice of Quarterly Results 30 Sept 2018
14th Aug 20187:00 amRNS2018 Interim Dividend
14th Aug 20187:00 amRNS2018 Interim Report and Accounts
14th Aug 20187:00 amRNS2018 Interim Results Highlights
31st Jul 20187:00 amRNSApax Funds' Valuations as at 30 June 2018
18th Jul 20183:00 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSDirectorate Change
2nd Jul 20183:00 pmRNSDirector Declaration
14th Jun 20187:00 amRNSNotice of Interim Results 2018
6th Jun 20187:00 amRNSAGA Investor Day
23rd May 201810:00 amRNSEU GDPR Data Privacy Notices
3rd May 20187:00 amRNSQuarterly results for 31 March 2018
1st May 20183:04 pmRNSResult of AGM
26th Apr 201812:47 pmRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Investor Day
19th Mar 20184:46 pmRNSDirector Declaration
19th Mar 201812:00 pmRNSNotice of AGM
14th Mar 20182:45 pmRNSNotice of Quarterly Results Q1 2018
6th Mar 20187:00 amRNS2017 Annual Dividend Announcement
6th Mar 20187:00 amRNS2017 Annual Report and Accounts
6th Mar 20187:00 amRNSUpdated Key Information Document
6th Mar 20187:00 amRNS2017 Final Results
31st Jan 20185:25 pmRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSApax Funds' Valuations as at 31 December 2017
4th Jan 20185:09 pmRNSDirectorate Change - Sarah Evans
2nd Jan 201812:00 pmRNSPublication of Key Information Document
15th Dec 20172:06 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSNotice of Annual Results
1st Nov 20177:00 amRNSQ3 2017 Results Highlights
11th Sep 20177:00 amRNS3Q17 Financial Highlights
31st Aug 20172:57 pmRNSAGA's FTSE Index Inclusion
17th Aug 20177:00 amRNS2017 Interim Dividend
17th Aug 20177:00 amRNS2017 Interim Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.